Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 28.09% | 414.25% | 200.79% | 706.16% | 416.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.09% | 414.25% | 200.79% | 706.16% | 416.11% |
| Cost of Revenue | 33.87% | 1,491.15% | 561.52% | 988.27% | 591.32% |
| Gross Profit | 20.48% | 187.58% | 88.95% | 500.87% | 286.88% |
| SG&A Expenses | -28.21% | 79.36% | 13.73% | 242.74% | 226.73% |
| Depreciation & Amortization | 65.52% | 57.26% | 44.35% | 3,828.57% | 12.62% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.79% | 363.67% | 161.77% | 521.26% | 381.27% |
| Operating Income | 104.54% | 682.23% | 558.19% | 665.75% | 911.37% |
| Income Before Tax | 212.16% | 1,377.60% | 954.68% | 361.54% | -2,455.36% |
| Income Tax Expenses | 171.75% | 8,492.86% | 6,445.00% | 1,233.33% | 221.43% |
| Earnings from Continuing Operations | 163.02% | 957.53% | 291.03% | 254.79% | -1,256.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 163.02% | 957.53% | 291.03% | 254.79% | -1,256.47% |
| EBIT | 104.54% | 682.23% | 558.19% | 665.75% | 911.37% |
| EBITDA | 101.02% | 520.59% | 391.43% | 1,028.90% | 507.73% |
| EPS Basic | 175.00% | 814.29% | 336.84% | 298.15% | -1,190.32% |
| Normalized Basic EPS | 193.14% | 1,182.35% | 1,118.18% | 457.89% | 1,233.33% |
| EPS Diluted | 175.00% | 814.29% | 336.84% | 298.15% | -1,190.32% |
| Normalized Diluted EPS | 193.14% | 1,182.35% | 1,118.18% | 457.89% | 1,233.33% |
| Average Basic Shares Outstanding | -15.97% | 21.34% | -10.01% | -21.67% | 4.90% |
| Average Diluted Shares Outstanding | -15.97% | 21.34% | -10.01% | -21.67% | 4.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |